Cataract Surgeons Gain a New Lens Tool - Report - MDSpire

Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

  • By

  • Kathryn Wighton

  • March 12, 2026

  • 3 min

Share

Clinical Report: FDA Approves TECNIS PureSee Intraocular Lens for Cataract Surgery

Overview

The TECNIS PureSee intraocular lens has received FDA approval for cataract surgery, designed to enhance vision while addressing presbyopia. Clinical evaluations indicate high patient satisfaction and comparable contrast sensitivity to traditional monofocal lenses, making it a promising option for patients.

Background

Cataracts are a prevalent condition associated with aging, affecting millions and leading to significant vision impairment. The introduction of advanced intraocular lenses (IOLs) like the TECNIS PureSee is crucial for improving patient outcomes in cataract surgery, which is one of the most commonly performed surgical procedures worldwide, with high success rates. This new lens aims to provide better visual acuity across different distances while minimizing common visual disturbances.

Data Highlights

No numerical data available in the provided source material; consider including relevant clinical data if accessible.

Key Findings

The TECNIS PureSee IOL is the first FDA-approved extended depth of focus IOL without warnings related to loss of contrast sensitivity. 97% of patients reported no very bothersome visual disturbances post-implantation, and 97% would recommend the lens to others. The lens provides improved intermediate visual acuity while maintaining comparable distance visual acuity to aspheric monofocal IOLs. A toric version is available for patients with significant preoperative corneal astigmatism.

Clinical Implications

The approval of the TECNIS PureSee IOL offers cataract surgeons a new option that enhances intermediate vision while preserving distance acuity. Clinicians should consider this lens for patients seeking to reduce dependence on reading glasses, particularly those with presbyopia, as it may significantly improve their quality of life.

Conclusion

The TECNIS PureSee intraocular lens represents a significant advancement in cataract surgery, providing patients with improved visual outcomes and high satisfaction rates. Its introduction may reshape the approach to managing presbyopia in cataract patients, offering a viable alternative to traditional lenses.

References

  1. Johnson & Johnson, FDA Press Release, 2026 -- TECNIS PureSee Intraocular Lens Approval
  2. Ophthalmology Management — SPOTLIGHT ON TECHNOLOGY & TECHNIQUE
  3. Ophthalmology Management — The femto evolution Recommendations
  4. Ophthalmology Management — Key Surgical Benefits
  5. Ophthalmology Management — Finding Success with the Light Adjustable Lens
  6. Ophthalmology Management — SPOTLIGHT ON TECHNOLOGY & TECHNIQUE
  7. Ophthalmology Management — The femto evolution Recommendations
  8. Ophthalmology Management — Key Surgical Benefits
  9. Quality of vision clinical outcomes for a new fully-refractive extended depth of focus Intraocular Lens
  10. Summary of Safety and Effectiveness (SSED) Template
  11. https://escrs.org/media/ooama3sf/full-extended-guideline-24092025.pdf

Original Source(s)

Cataract Surgeons Gain a New Lens Tool

  • by Kathryn Wighton

  • March 12, 2026

Related Content

Comparison of early clinical and optical quality-related outcomes after SMILE using VisuMax 800 versus VisuMax 500 for myopia and low-to-moderate astigmatism in a Chinese population: a single-center retrospective study

Eye on OOSS: Advocacy Matters, and It Works

In an increasingly complex health care environment, the combination of strong advocacy, collaborative learning, and access to actionable resources, positions OOSS members for continued success.

Solving the Data Challenge in Ophthalmic AI

At ARVO, Cecilia S. Lee, MD, MS, and Aaron Y. Lee, MD, MSCI, discuss barriers to AI deployment in ophthalmology, including interoperability and model development.